SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-08-15 |
| Reported value | $14,214,935,834 |
| Positions | 19 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP | SPCX | CLASS A COM STK | $12,789,728,717 | 74,855,020 |
| NAVAN INC | NAVN | CL A | $645,361,120 | 28,218,676 |
| REVOLUTION MEDICINES INC | RVMD | COM | $172,503,421 | 921,099 |
| META PLATFORMS INC | META | CL A | $119,716,587 | 212,531 |
| FIGMA INC | FIG | CLASS A COM STK | $108,238,042 | 5,983,308 |
| BIOAGE LABS INC | BIOA | COM | $79,244,997 | 3,233,170 |
| BLOCK INC | XYZ | CL A | $77,268,972 | 1,016,697 |
| ERASCA INC | ERAS | COM | $52,441,000 | 2,862,500 |
| MAZE THERAPEUTICS INC | MAZE | COM | $50,794,394 | 1,702,225 |
| DAMORA THERAPEUTICS INC | DMRA | COM NEW | $32,152,444 | 1,236,157 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.